Qube Research & Technologies (QRT)
ABCL icon

Qube Research & Technologies (QRT)’s AbCellera Biologics ABCL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-122,592
Closed -$419K – 3482
2025
Q4 		$419K Buy
+122,592
New +$547K ﹤0.01% 2854
2023
Q4 		– Sell
-26,967
Closed -$124K – 4297
2023
Q3 		$124K Buy
+26,967
New +$164K ﹤0.01% 2583
2023
Q2 		– Sell
-95,621
Closed -$721K – 2335
2023
Q1 		$721K Sell
95,621
-162,896
-63% -$1.48M ﹤0.01% 1421
2022
Q4 		$2.62M Buy
258,517
+206,750
+399% +$2.39M 0.01% 857
2022
Q3 		$512K Buy
+51,767
New +$568K ﹤0.01% 1456
2022
Q2 		– Sell
-149,417
Closed -$1.46M – 2429
2022
Q1 		$1.46M Buy
149,417
+129,744
+660% +$1.23M 0.01% 969
2021
Q4 		$281K Buy
+19,673
New +$299K ﹤0.01% 1831

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return